Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Shou-feng Jiao"'
Aims: With the extensive use of tyrosine kinases inhibitors(TKIs) in hepatocellular cancer, cardiac adverse events(AEs) emerged in recent years. This study explored the cardiac AEs of TKIs through the Food and Drug Administration’s Adverse Event Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c9df883258461c529a61e13b8449f39
https://doi.org/10.22541/au.168132604.49189532/v1
https://doi.org/10.22541/au.168132604.49189532/v1
Publikováno v:
Journal of Applied Polymer Science; December 2006, Vol. 102 Issue: 6 p5633-5639, 7p
